IRulya Therapeutics QNCX
NASDAQ QNCX
$34.45 +2.42 (+7.56%)
At close: Oct 19, 2026 · 4:00 PM EDT

Quince Therapeutics, Inc. (QNCX) EBITDA (2018 - 2026)

Updated

Quince Therapeutics (QNCX) reported EBITDA of -$79.74 million for Q2 2026, compared with -$10.39 million a year earlier.

Analysis

Quince Therapeutics, Inc. (QNCX) EBITDA (2018 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Quince Therapeutics' EBITDA came in at -$127 million; for FY2025, it came in at -$57.93 million.

  • By year, EBITDA came in at -$57.1 million in FY2024, -$34.3 million in FY2023, -$51.81 million in FY2022 and -$89.97 million in FY2021.
  • The Q2 2026 figure ranks as the lowest quarterly EBITDA in data going back to Q1 2018.
  • Per Business Quant data, the three quarters before Q2 2026 came in at -$14.55 million (Q1 2026), -$19.31 million (Q4 2025) and -$13.39 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -79.74 Mn
Mar 31, 2026 -14.55 Mn
Dec 31, 2025 -19.31 Mn
Sep 30, 2025 -13.39 Mn
Jun 30, 2025 -10.39 Mn
Mar 31, 2025 -14.83 Mn
Dec 31, 2024 -12.00 Mn
Sep 30, 2024 -5.78 Mn
Jun 30, 2024 -28.15 Mn
Mar 31, 2024 -11.18 Mn
Dec 31, 2023 -9.62 Mn
Sep 30, 2023 -6.09 Mn
Jun 30, 2023 -5.58 Mn
Mar 31, 2023 -12.94 Mn
Dec 31, 2022 -6.28 Mn
Sep 30, 2022 -7.58 Mn
Jun 30, 2022 -16.17 Mn
Mar 31, 2022 -21.83 Mn
Dec 31, 2021 -23.46 Mn
Sep 30, 2021 -21.59 Mn
API Access

Quince Therapeutics, Inc. EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=QNCX&period=max&api_key=YOUR_API_KEY